Skip to main content

JHOP - March 2026 Vol 16 Special Feature

Download HOPA Abstracts

Editorial
HOPA Abstracts
Perspective
Editorial
Editorial
Hope Springs Eternal: A New Year of HOPA Annual Conference Research Abstracts
Courtney C. Cavalieri, PharmD, BCOP; Michael Williams, PharmD, BCOP
Read More
HOPA Abstracts
HOPA Abstracts
Evaluation of a Biosimilar Conversion in an Academic Medical Center Outpatient Infusion Center
Abstract #CR01
Sidney Keisner, PharmD, BCOP
Read More
HOPA Abstracts
Outcomes of Supportive Care Versus Pharmacologic Intervention for the Management of CRS in Relapsed or Refractory Multiple Myeloma Treated With BCMA- and GPRC5D-Directed Bispecifics
Abstract #CR02
Victoria Nachar, PharmD, BCOP; James Davis, PharmD, BCOP
Read More
HOPA Abstracts
From Diagnosis to Decision-Making: Black Patient and Caregiver Perspectives on Lung Cancer Care and Support Needs
Abstract #CR03
Shanada Monestime, PharmD, BCOP
Read More
HOPA Abstracts
Safety of Live-Attenuated MMR Vaccination in Patients With Multiple Myeloma Receiving Daratumumab After Autologous Stem-Cell Transplantation
Abstract #CR04
James A. Davis, PharmD, BCOP
Read More
HOPA Abstracts
A Real-World Analysis of Filgrastim and Biosimilars for Engraftment After Hemopoietic Cell Transplantation: Balancing Efficacy and Economics
Abstract #CR05
Dennis Marjoncu, PharmD, BCOP; Kori Holman, PharmD, BCOP
Read More
HOPA Abstracts
Impact of an Oncolytic Pharmacist Prescription Verification Queue at an Academic Medical Center
Abstract #CR06
Kelsea Seago, PharmD, BCOP; Christine Barrett, PharmD, BCOP
Read More
HOPA Abstracts
Dexamethasone Versus Tocilizumab for Management of Talquetamab-Induced Cytokine Release Syndrome in Patients With Relapsed/Refractory Multiple Myeloma: A Multicenter, Retrospective Study
Abstract #CR07
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP
Read More
HOPA Abstracts
Phase 3 Study to Evaluate Efficacy and Safety of Pemivibart, an IgG1 Monoclonal Antibody, for the Prevention of COVID-19 (CANOPY): Subset Analysis of Participants With Chronic Lymphocytic Leukemia
Abstract #CR08
Kirthana Beaulac, PharmD
Read More
HOPA Abstracts
Safety of Shortened Postinfusion Observation Times for Pertuzumab and Ado-trastuzumab Emtansine: Retrospective and Prospective Analyses
Abstract #CR09
Jennifer Hutchinson, PharmD, BCOP
Read More
HOPA Abstracts
Real-World Incidence of Infusion-Related Reactions With Sacituzumab Govitecan and Opportunities for Premedication De-Escalation
Abstract #CR10
Jennifer Hutchinson, PharmD, BCOP
Read More
HOPA Abstracts
Imlunestrant With or Without Abemaciclib in Advanced Breast Cancer: Safety Analyses From the Phase 3 EMBER-3 Trial
Abstract #CR11
Emily Barrett, MSc
Read More
HOPA Abstracts
Assessment of Thromboprophylaxis Eligibility in Patients With Cancer at a Community Hospital
Abstract #CR12
Christopher Clayton, PharmD, BCOP; Sol Atienza, PharmD, BCOP
Read More
HOPA Abstracts
Prostate-Specific Antigen Response With Darolutamide Plus Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer in ARANOTE
Abstract #CR13
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, FHOPA
Read More
HOPA Abstracts
Pilot Study to Establish Incidence and Characteristics of Patients at Risk for Symptomatic Hyperammonemia Secondary to Recombinant Erwinia Asparaginase
Abstract #CR14
Catherine Martin, PharmD; Alexis Kuhn, PharmD, BCOP
Read More
HOPA Abstracts
CMV Reactivation With Bispecific Antibodies in Multiple Myeloma
Abstract #CR15
Jordan Snyder, PharmD, BCOP
Read More
HOPA Abstracts
Two-Year Real-World Patient-Reported Outcomes in Newly Diagnosed Patients With Immune Thrombotic Thrombocytopenic Purpura After Caplacizumab Plus Therapeutic Plasmatic Exchange Treatment: A Prospective, Observational Study
Abstract #CR16
Jennifer Wang, PharmD; Laurence Pollissard, MSc; Jennifer Wang; Marco Rossetti, BSBA; Synne Wing, MSW
Read More
HOPA Abstracts
Factors Associated With Clinical Outcomes in Patients With HER2 Mutation–Positive NSCLC Who Received Sevabertinib (BAY 2927088)
Abstract #CR17
Katelyn Toeniskoetter, PharmD, BCOP
Read More
HOPA Abstracts
SOHO-01: Safety and Efficacy of Sevabertinib in Patients With Advanced HER2 Mutation–Positive Non–Small Cell Lung Cancer Who Received Pretreatment but Were Naïve to HER2-Targeted Therapy or Had Not Received Any Treatment for Advanced Disease
Abstract #CR18
Katelyn Toeniskoetter, PharmD, BCOP
Read More
HOPA Abstracts
Automating Dose Rounding Within the Electronic Health Record: Impact on Drug Waste and Cost Avoidance
Abstract #CR19
Sarah Hogue, PharmD;
Read More
HOPA Abstracts
Treatment Persistence and Dose Modifications in US Patients With Hormone Receptor–Positive, HER2-Negative, Node-Positive, Early Breast Cancer Treated With Adjuvant Abemaciclib
Abstract #CR20
Astra Liepa, PharmD, BS
Read More
HOPA Abstracts
Operational and Financial Impact of Electronic Medical Record–Integrated Biomarker Testing Workflows on Specialty Pharmacy in Non–Small Cell Lung Cancer
Abstract #CR21
Kelsey Schildknecht, PharmD; Lauren Gilmer, PharmD
Read More
HOPA Abstracts
Oxaliplatin Desensitization—A Promising Approach for Patients With Cancer and Hypersensitivity Reactions: Real-World Experience From Vietnam
Abstract #LB01
Le Trang Nguyen
Read More
HOPA Abstracts
Infusion Pharmacist–Driven Romiplostim Dosing Protocol to Optimize Efficiency in an Outpatient Hematology and Oncology Cancer Center
Abstract #LB02
Ashley Jones, PharmD, BCOP; Hetalkumari Patel, PharmD, BCOP; Kailee Gaines, PharmD, BCOP
Read More
HOPA Abstracts
Pharmacist-Led Management of Vorasidenib in Patients With Isocitrate Dehydrogenase Mutation–Positive Gliomas
Abstract #LB03
Marie Noelle Bate Baiyee, PharmD; Mary Hilliger, PharmD; Bilge Parlakkilic, PharmD
Read More
HOPA Abstracts
Building Real-World Evidence Through the HERO Consortium: A Pharmacist-Led Multicenter Initiative
Abstract #LB04
Ila M. Saunders, PharmD, BCOP; Sarah Profitt, PharmD, BCOP
Read More
HOPA Abstracts
Hybrid Observation Model for Bispecific T-Cell Engager
Abstract #LB05
Alyssa Cendagorta, PharmD, BCOP
Read More
HOPA Abstracts
Pharmacist and Nurse Preferences for Preparing Large-Volume Subcutaneous Oncology Drugs During a Patient Capacity Crisis in the United Kingdom: A Discrete-Choice Study Comparing Manual Syringe Versus an On-Body Injector
Abstract #LB06
Haydon DuMond, PharmD
Read More
Perspective
Online First
Perspective, Clinical Trials
North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval
Ming-Hei Tai, PharmD, BCOP
Read More